Evidence map›Paper›PMID 25605878›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Maria A Riolo, Pejman Rohani

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Pertussis vaccines, epidemiology and evolution.Nature reviews. Microbiology · 2024
    Review
  6. Disentangling the causes of mumps reemergence in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  9. COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope.medRxiv : the preprint server for health sciences · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Use of a 40-day rolling incidence to monitor pertussis in Nova Scotia, 2015.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2017
    Article
  15. Forecasting Epidemiological Consequences of Maternal Immunization.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  16. Effectiveness of pertussis vaccination and duration of immunity.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maria A RioloDepartments of Mathematics and Center for the Study of Complex Systems, University of Michigan, Ann Arbor, MI 48109; and mariolo@umich.edu.
Pejman RohaniCenter for the Study of Complex Systems, University of Michigan, Ann Arbor, MI 48109; and Ecology & Evolutionary Biology, and Fogarty International Center, National Institutes of Health, Bethesda, MD 20892.

Funding

Understanding Transmission with Integrated Genetic and Epidemiologic InferenceU54GM111274 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2014 to 2018
$12.5M
Integrating immunology, epidemiology, and evolution to understand and control perR01AI101155 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KING, AARON A., ROHANI, PEJMAN · 2012 to 2016
$1.7M
NIAID NIH HHS R01 AI101155NIAID NIH HHS R01AI101155NIGMS NIH HHS U54 GM111274NIGMS NIH HHS U54-GM111274
6 · The paper itself

Abstract

Pertussis has reemerged as a major public health concern in many countries where it was once considered well controlled. Although the mechanisms responsible for continued pertussis circulation and resurgence remain elusive and contentious, many countries have nevertheless recommended booster vaccinations, the timing and number of which vary widely. Here, using a stochastic, age-stratified transmission model, we searched for cost-effective booster vaccination strategies using a genetic algorithm. We did so assuming four hypothesized mechanisms underpinning contemporary pertussis epidemiology: (I) insufficient coverage, (II) frequent primary vaccine failure, (III) waning of vaccine-derived protection, and (IV) vaccine "leakiness." For scenarios I-IV, successful booster strategies were identified and varied considerably by mechanism. Especially notable is the inability of booster schedules to alleviate resurgence when vaccines are leaky. Critically, our findings argue that the ultimate effectiveness of vaccine booster schedules will likely depend on correctly pinpointing the causes of resurgence, with misdiagnosis of the problem epidemiologically ineffective and economically costly.

Indexed as

Disease OutbreaksHumansImmunization SchedulePertussis VaccineWhooping CoughPertussis Vaccinebooster schedulegenetic algorithmimmunizationpertussis

Identifiers

PMID25605878
PMCPMC4321240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.